Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Adavosertib in Treating Patients with SETD2-Deficient Locally Advanced or Metastatic Solid Tumors

This phase II trial studies how well adavosertib works in treating patients with SETD2-deficient solid tumors that have spread to other places in the body (advanced / metastatic). Adavosertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Not Available
II
Rathmell, Kim
NCT03284385
VICCURO18153ET-CT

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: